NCT01519869
- Conditions
- Adnexal Diseases, Carcinoma, Endocrine Gland Neoplasms, +20 more
- Locations
-
- University of Kentucky Markey Cancer Center Lexington, Kentucky, United States
Clinical trial condition
Fallopian Tube Diseases
Explore clinical trials studying Fallopian Tube Diseases. Study availability and eligibility vary by location and protocol.
598 public trials
89 recruiting studies
Fallopian Tube Diseases trial results
NCT00436215
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT03704467
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
- Locations
-
- Marin Cancer Care, Inc. Greenbrae, California, United States
- The Stamford Hospital Stamford, Connecticut, United States
- Covenant Health Care Saginaw, Michigan, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer
NCT03480750
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
- Locations
-
Not specified
NCT02283658
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT01899599
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- Investigator Berlin, Germany
- Investigator Kiel, Germany
- Investigator Munich, Germany
- Investigator Munich, Germany
NCT00391118
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +21 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leuven, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Liège, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Düsseldorf, Germany
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Arizona Oncology Associates, PC - HAL Tempe, Arizona, United States
- Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
- UCLA Women's Health Clinical Research Unit - OBGYN Los Angeles, California, United States
NCT01199263
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
- Palo Alto Medical Foundation-Gynecologic Oncology Mountain View, California, United States
- Smilow Cancer Hospital Care Center at Saint Francis Hartford, Connecticut, United States
- Northeast Georgia Medical Center-Gainesville Gainesville, Georgia, United States
NCT01649336
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
- Locations
-
- Pfizer Investigational Site Scottsdale, Arizona, United States
- Pfizer Investigational Site Lafayette, Indiana, United States
- Pfizer Investigational Site New York, United States
- Pfizer Investigational Site Oklahoma City, Oklahoma, United States